Top 28 Visen Pharmaceuticals investors
The most complete profiles first. Showing 28 of 28.
Albert ChaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 81 more
Verified email available
David BonitaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more
Verified email available
Geoffrey HsuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan LeffVerified
Venture Capital, Investor · United States
SeedSeries BHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more
Verified email available
Mahendra ShahVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Verified email available
Nathan DauVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Verified email available
Sarah BhagatVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Alan ColowickVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Jason PittsVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Jonathan SilversteinVerified
Private Equity Firm · United States
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WangVerified
Private Equity Firm · China
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Mike PowellVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Qi ZhuVerified
Venture Capital, Private Equity Firm · China
Health CareHospitalsWomen FoundedInvestment ManagementPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Verified email available
Rishi GuptaVerified
Private Equity Firm · United States
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Carter Neild
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Chau Khuong
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more
Contact details available
Frank Kung
Venture Capital, Founder, Private Equity Firm · United States
Series BHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 76 more
Contact details available
Maha Katabi, PhD, CFA
Hedge Fund, Venture Capital, Investor · Canada
SeedHealth CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more
Contact details available
Perry Nisen
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Scotland Stevens
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Alfred Yue
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Anat Naschitz
Private Equity Firm · Israel
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Andrew Goldberg
Venture Capital, Private Equity Firm · United States
Health CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Contact details available
Erez Chimovits
Private Equity Firm · Israel
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Hooman Shahlavi
Hedge Fund, Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Nina Feng
Venture Capital, Private Equity Firm · Taiwan
Health CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Contact details available
Shan Fu
Venture Capital, Private Equity Firm · China
Health CareHospitalsWomen FoundedInvestment ManagementPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Contact details available
Dandan DongVerified
Venture Capital, Investor · United States
Series BBiotechnologyElectronic Health Records (EHR)Health and Hospital ServicesDigital HealthPortfolio: Kira Pharmaceuticals, Visen Pharmaceuticals
Verified email available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Visen Pharmaceuticals investors are on Angel Roster?
Angel Roster lists 28 Visen Pharmaceuticals investors. 15 of them (54%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (23), Private Equity Firms (18) and Hedge Funds (2). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Visen Pharmaceuticals investors invest in?
Among those that list a stage, the most common are Seed (10), Series B (5) and Series A (5).
Where are Visen Pharmaceuticals investors based?
Most are based in the United States (21), China (3) and Israel (2).
Which companies have Visen Pharmaceuticals investors backed?
The most-backed portfolio companies among them are VelosBio (19), Verona Pharma (18), Harmony Biosciences (18), Rongchang Pharmaceutical (18) and Gracell Biotechnologies (18).
How do I contact Visen Pharmaceuticals investors?
Create a free Angel Roster account to search and filter all 28, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.